Kailera Therapeutics, Inc. (KLRA)
NASDAQ: KLRA · Real-Time Price · USD
20.83
+0.17 (0.82%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Kailera Therapeutics Market Cap
Kailera Therapeutics has a market cap or net worth of $2.7 billion as of June 29, 2026.
Market Cap
2.70B
Enterprise Value
2.13B
1-Year Change
n/a
Ranking
Category
Stock Price
$20.83
Market Cap Chart
Since the IPO on April 17, 2026, Kailera Therapeutics's market cap has increased from $1.98B to $2.70B, an increase of 36.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 2.70B | 0.82% |
| Jun 25, 2026 | 2.68B | -3.32% |
| Jun 24, 2026 | 2.77B | - |
| Jun 23, 2026 | 2.77B | -6.60% |
| Jun 22, 2026 | 2.96B | 14.97% |
| Jun 18, 2026 | 2.58B | 4.03% |
| Jun 17, 2026 | 2.48B | 3.13% |
| Jun 16, 2026 | 2.40B | -5.69% |
| Jun 15, 2026 | 2.55B | 4.13% |
| Jun 12, 2026 | 2.45B | -3.33% |
| Jun 11, 2026 | 2.53B | 2.09% |
| Jun 10, 2026 | 2.48B | -2.55% |
| Jun 9, 2026 | 2.54B | -0.30% |
| Jun 8, 2026 | 2.55B | 1.70% |
| Jun 5, 2026 | 2.51B | -7.72% |
| Jun 4, 2026 | 2.72B | -6.21% |
| Jun 3, 2026 | 2.90B | -0.93% |
| Jun 2, 2026 | 2.93B | -2.55% |
| Jun 1, 2026 | 3.00B | 1.05% |
| May 29, 2026 | 2.97B | - |
| May 28, 2026 | 2.97B | 4.70% |
| May 27, 2026 | 2.84B | 1.58% |
| May 26, 2026 | 2.79B | 1.91% |
| May 22, 2026 | 2.74B | 0.43% |
| May 21, 2026 | 2.73B | 5.03% |
| May 20, 2026 | 2.60B | 2.29% |
| May 19, 2026 | 2.54B | 0.36% |
| May 18, 2026 | 2.53B | -7.08% |
| May 15, 2026 | 2.73B | -2.14% |
| May 14, 2026 | 2.79B | 1.85% |
| May 13, 2026 | 2.73B | -5.34% |
| May 12, 2026 | 2.89B | -2.75% |
| May 11, 2026 | 2.97B | 6.80% |
| May 8, 2026 | 2.78B | -4.45% |
| May 7, 2026 | 2.91B | -9.03% |
| May 6, 2026 | 3.20B | 1.81% |
| May 5, 2026 | 3.14B | -3.31% |
| May 4, 2026 | 3.25B | -0.24% |
| May 1, 2026 | 3.26B | 0.60% |
| Apr 30, 2026 | 3.24B | 0.97% |
| Apr 29, 2026 | 3.21B | 3.95% |
| Apr 28, 2026 | 3.09B | 1.32% |
| Apr 27, 2026 | 3.05B | 4.63% |
| Apr 24, 2026 | 2.91B | -10.41% |
| Apr 23, 2026 | 3.25B | 3.21% |
| Apr 22, 2026 | 3.15B | -3.65% |
| Apr 21, 2026 | 3.27B | 2.48% |
| Apr 20, 2026 | 3.19B | 61.10% |
| Apr 17, 2026 | 1.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enliven Therapeutics | 3.05B |
| Vera Therapeutics | 3.05B |
| Ultragenyx Pharmaceutical | 3.02B |
| Disc Medicine | 2.86B |
| Celldex Therapeutics | 2.77B |
| Tarsus Pharmaceuticals | 2.71B |
| Trevi Therapeutics | 2.58B |
| MBX Biosciences | 2.49B |